MKT-077-FJ-776-DataSheet-生命科学试剂-MedChemExpress_第1页
MKT-077-FJ-776-DataSheet-生命科学试剂-MedChemExpress_第2页
MKT-077-FJ-776-DataSheet-生命科学试剂-MedChemExpress_第3页
MKT-077-FJ-776-DataSheet-生命科学试剂-MedChemExpress_第4页
全文预览已结束

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEMKT-077Cat. No.: HY-15096CAS No.: 147366-41-4Synonyms: FJ-776分式: CHClNOS分量: 432作靶点: HSP作通路: Cell Cycle/DNA Damage; Metabolic Enzyme/Protease储存式: Powder -20C 3 yearsIn solvent -80C 6 months-20C 1 month溶解性数据体外实验 DMSO : 41.67 mg/mL

2、 (96.46 mM; Need ultrasonic)Mass Solvent1 mg 5 mg 10 mg Concentration制备储备液1 mM 2.3148 mL 11.5741 mL 23.1481 mL5 mM 0.4630 mL 2.3148 mL 4.6296 mL10 mM 0.2315 mL 1.1574 mL 2.3148 mL请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液,并请注意储备液的保存式和期限。体内实验 请根据您的实验动物和给药式选择适当的溶解案,配制前请先配制澄清的储备液,再依次添加助溶剂(为保证实验结果的可靠性,体内实验的作液,建议您现现配,

3、当天使;澄清的储备液可以根据储存条件,适当保存;以下溶剂前的百分 指该溶剂在您配制终溶液中的体积占):1. 请依序添加每种溶剂: 10% DMSO 40% PEG300 5% Tween-80 45% salineSolubility: 2.08 mg/mL (4.81 mM); Clear solution2. 请依序添加每种溶剂: 10% DMSO 90% corn oilSolubility: 2.08 mg/mL (4.81 mM); Clear solution1/3 Master of Small Molecules 您边的抑制剂师www.MedChemEBIOLOGICAL AC

4、TIVITY物活性 MKT-077种花菁染料,也 种热休克蛋 70 (Hsp70) 抑制剂,且具有显着的抗肿瘤活性。IC50 & Target HSP70体外研究 MKT-077 is a rhodacyanine dye and also a heat shock protein 70 (Hsp70) inhibitor which exhibits significantantitumor activity. MKT-077 treatment (0.1 to 10 M dose ranges) for 48 hours can effectively decrease TTcell vi

5、ability. MKT-077 treatment results in accumulation of cells in the G0/G1 phase in a dose-dependentmanner, and also increases sub-G0/G1 phase population in TT cell culture in a dose-dependent manner.MKT-077 also downregulates cellular levels of the proliferation marker, Ki67, and the S-phase transcri

6、ptionfactor, E2F-1, in TT and MZ-CRC-1 cells. Moreover, flow cytometry using different doses of MKT-077reveales that TT cells can uptake and retain MKT-077 at significantly higher levels than MZ-CRC-1 cells 1.MKT-077 has EC50 values of 1.40.2 and 2.20.2 M against MDA-MB-231 and MCF7 breast cancer ce

7、lls,respectivelyl 2.体内研究 Systemic administration of MKT-077 significantly delays the growth of TT xenografts in mice throughout thetreatment. At the end of MKT-077 treatment, it is found that tumor weights are about two-times less in MKT-077-treated group than in control group. MKT-077 treatment als

8、o results in weight loss and general toxicity inanimals 1. Results show that the succinate-induced, ADP-stimulated respiratory rate in mitochondriaisolated from the liver of rats treated with a bolus i.v. injection of 15 mg MKT-077 1kg body weight each dayfor 5 days is significantly lower than that

9、of untreated controls 3.PROTOCOLCell Assay 1 Cells are incubated with 1 M MKT-077 and 100 nM Mitotracker Green FM in culture medium for 30 minutesat 37C in the dark, washed with PBS, switched into phenol-red free medium before visualizing fluorescenceunder a microscope. Pictures are acquired and pro

10、cessed with software. For flow cytometric measurement,MKT-077-treated cells are resuspended in 0.1% bovine serum albumin/PBS and analyzed by flow cytometry.Data from 20,000 cells are analyzed using FCS Express software 1.MCE has not independently confirmed the accuracy of these methods. They are for

11、 reference only.Animal The 1107 TT cells in 200 L Hanks balanced salt solution are inoculated subcutaneously into the rearAdministration 1 flanks of 6-week-old female athymic nude (nu/nu) mice. Once palpable, tumors are measured using calipersat intervals indicated in the text. When tumor volume rea

12、ches 100 mm3, mice are sorted into groups of 8 toachieve equal distribution of tumor size in all treatment groups. Group 1 receives only the vehicle (1:9mixture of DMSO/saline) and group 2 receives MKT-077 (10 mg/kg body weight/dose). A 200 L of ethersolution is administered by intraperitoneal injec

13、tion every 2 days (total 10 doses). At the end of theexperiments, animals are euthanized by CO2 asphyxiation 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.REFERENCES2/3 Master of Small Molecules 您边的抑制剂师www.MedChemE1. Starenki D, et al. Selective Mit

14、ochondrial Uptake of MKT-077 Can Suppress Medullary Thyroid Carcinoma Cell Survival In Vitro and InVivo. Endocrinol Metab (Seoul). 2015 Dec;30(4):593-603.2. Li X, et al. Analogs of the Allosteric Heat Shock Protein 70 (Hsp70) Inhibitor, MKT-077, as Anti-Cancer Agents. ACS Med Chem Lett.2013 Nov 14;4(11).3. Weisberg EL, et al. In vivo administration of MKT-077 causes partial yet reversible impairment of mitochondrial function. Cancer Res.1996 Fe

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论